Back to Directory

Rebecca Roba (Dirschberger)

Email

dirsch@frontierscience.org

Phone

716-834-0900 ext. 7268

Institution

Frontier Science

Address

Frontier Science Foundation
4033 Maple Road
Amherst, NY 14226

Request an Update

Affiliated Studies

IMPAACT 2047: Radiant-Moms Plus

DAIDS Number

Research Area

Study Status

IMPAACT 2051: Phase II Study of the Pharmacokinetics, Safety, Tolerability, and Anti-Mycobacterial Activity of Pretomanid with Bedaquiline and Linezolid, with or without Moxifloxacin, in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

IMPAACT 2050: CREATE

DAIDS Number

Research Area

Study Status

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2044: Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy

DAIDS Number

Research Area

Study Status

Show All